The number of compounds discovered at selected false discovery rates upon application of CG-TARGET to data from two large-scale chemical-genetic interaction screens.
- Scott W. Simpkins (3295239)
- Justin Nelson (1858081)
- Raamesh Deshpande (235569)
- Sheena C. Li (1856425)
- Jeff S. Piotrowski (1856434)
- Erin H. Wilson (5909036)
- Abraham A. Gebre (5909039)
- Hamid Safizadeh (5909042)
- Reika Okamoto (5909045)
- Mami Yoshimura (5909048)
- Michael Costanzo (178059)
- Yoko Yashiroda (2270305)
- Yoshikazu Ohya (10098)
- Hiroyuki Osada (251592)
- Minoru Yoshida (151970)
- Charles Boone (21213)
- Chad L. Myers (53909)
Publication date
November 2018
DOI Publisher
Public Library of Science (PLoS)Abstract
The “RIKEN” screen consisted of 8418 total compounds from the RIKEN Natural Product Depository, and the “NCI/NIH/GSK” screen consisted of 3565 compounds across 6 chemical compound collections from the National Cancer Institute, National Institutes of Health, and GlaxoSmithKline.</p
Add to ORKG